Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Micreos Human Health
Bilthoven, North Holland, Netherlandsmicreos.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Micreos Human Health is a clinical-stage biotechnology company pioneering the development of targeted antibacterial solutions using endolysin technology. Unlike traditional antibiotics, the company's proprietary endolysins specifically target and kill pathogenic bacteria like Staphylococcus aureus while preserving the beneficial microbiome. Their lead clinical candidate, XZ.700, is being evaluated for inflammatory skin conditions such as atopic dermatitis. Micreos also markets over-the-counter products under the Gladskin brand, which utilize their Staphefekt enzyme to manage skin microbiome imbalances.
- Therapeutic areas
- EndocrinologyDermatologyInfectious Diseases
- Modalities
- Recombinant proteinEnzymeEndolysin
- Industry
- Biotech
Beyond the preview
Go deeper on Micreos Human Health.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Micreos Human Health.